This session will cover key concepts related to implementing intensity modulated radiotherapy (IMRT) and stereotactic body radiotherapy (SBRT) gastrointestinal (GI) cancers. Updates on clinical outcome data using IMRT and SBRT, including survival and toxicity, will be presented.